DocDollars

Opko Pharmaceuticals, LLC

FL · United States · Reporting entity ID 100000151639

Total reported 2019–2025
$10.6M
#474 of 2,960 reporting companies — 0% of all reported industry payments
$1.45M in general payments across 47,034 records, plus $9.16M in research funding across 683 records.

How it breaks down

General payments $1,446,515
Research funding $9,161,653

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Opko Pharmaceuticals, LLC reported $10.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #474 of 2,960 reporting companies. 86% of that was research funding and 14% general payments such as consulting, speaking, food and travel. 47,034 general payment records and 683 research records were filed.

Common questions about Opko Pharmaceuticals, LLC

How much has Opko Pharmaceuticals, LLC paid US doctors?

Opko Pharmaceuticals, LLC reported $10,608,168 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,446,515 in general payments, $9,161,653 in research funding.

How does Opko Pharmaceuticals, LLC rank among drug and device companies?

It ranks #474 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Opko Pharmaceuticals, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.